Advertisement

Topics

Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups

05:45 EDT 9 Aug 2017 | Forbes

Vivek Ramaswamy, a former hedge fund partner who went on to engineer one of the biggest biotech initial public offerings in history, has a new source of cash: his investment vehicle, Roivant Sciences, just raised $1.1 billion from investors including the Softbank Vision Fund and Dexcel Pharma.

Original Article: Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups

NEXT ARTICLE

More From BioPortfolio on "Biotech Wunderkind Raises $1.1 Billion To Fund Pharma Startups"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...